Expert Review of Gastroenterology & Hepatology 2013-03-01

The role of antimicrobials in Crohn's disease.

Pramodini B Kale-Pradhan, Jing J Zhao, Jennifer R Palmer, Sheila M Wilhelm

文献索引：Expert Rev. Gastroenterol. Hepatol. 7(3) , 281-8, (2013)

全文：HTML全文

摘要

This review summarizes literature regarding the role of antimicrobials for induction and maintenance of Crohn's disease (CD) remission. PubMed was searched (1966 to October 2012) for controlled trials involving adults and written in English. Five of the 13 identified studies showed benefit with the use of ciprofloxacin, metronidazole and rifaximin for induction of remission. Eight studies showed no benefit using ciprofloxacin, metronidazole, combination of metronidazole and ciprofloxacin or clarithromycin and rifaximin. Four of the five studies showed benefit based on colonic location. Perianal CD with draining fistulas responded in one of two studies. Two studies in postileocolonic resection demonstrated benefit of metronidazole or ornidazole in reducing CD recurrence. Antimicrobials, especially metronidazole, are promising for inducing remission in patients with colonic CD and preventing recurrence in postileocolonic resection.